UPDATE: Deutsche Bank Initiates Coverage on MedAssets with Buy Rating, $27 PT on Attractive Valuation

In a report published Thursday, Deutsche Bank analyst George Hill initiated coverage on MedAssets MDAS with a Buy rating and $27.00 price target. In the report, Deutsche Bank noted, “We are initiating coverage of MedAssets with a Buy rating, highlighting the company's attractive valuation. We expect MedAssets to grow revenue in line with the growth in hospital spending and to generate annual margin improvement. Our forecast is that overall hospital utilization will remain modest with a small benefit from additional patients coming from healthcare reform. We view MedAssets as well positioned for population health as provider and administrator facing tools for cost management are important components of our PHM framework. We view MDAS shares as attractive currently trading at 14x our 2015 EPS estimate.” MedAssets closed on Wednesday at $20.56.